Find recruiting clinical trials for osteoporosis in the UK — including post-menopausal, male, and glucocorticoid-induced osteoporosis. See treatment pathways and where trials fit in.
Free to use — Live data from ClinicalTrials.gov — Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
Initial treatment
Standard: Alendronic acid (Fosamax) or Risedronate — weekly oral bisphosphonate
Building new bone
Standard: Teriparatide (Forteo) or Romosozumab (Evenity) for high fracture risk
Subcutaneous injection
Standard: Denosumab (Prolia) — twice-yearly injection for those intolerant of bisphosphonates
The most common group. Oestrogen decline after menopause accelerates bone loss. About 1 in 2 women over 50 will break a bone due to osteoporosis.
Less commonly recognised but affects about 1 in 5 men over 50. Often under-diagnosed. Testosterone deficiency is a contributing factor.
Caused by long-term steroid use (e.g. Prednisolone). Rapid bone loss can occur. Requires early intervention with bone-protective therapy.
Loading trials from ClinicalTrials.gov...
Romosozumab (Evenity) is a bone-building (anabolic) treatment given as monthly injections for 12 months. It is approved by NICE for postmenopausal women at very high fracture risk. Trials are exploring expanded use.
Most osteoporosis trials run 1-3 years to measure changes in bone mineral density and fracture rates. Some long-term extension studies continue for 5-10 years.
Yes. Many trials specifically include men, and some focus exclusively on male osteoporosis. Treatment options for men are expanding, and trials are helping establish best practices.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.